![Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2458-14-991/MediaObjects/12889_2014_Article_7304_Fig1_HTML.jpg)
Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text
![Hepatitis B vaccination (Engerix-B®) study design. 340 a Hepatitis B... | Download Scientific Diagram Hepatitis B vaccination (Engerix-B®) study design. 340 a Hepatitis B... | Download Scientific Diagram](https://www.researchgate.net/publication/343866719/figure/fig1/AS:928586198433793@1598403610970/Hepatitis-B-vaccination-Engerix-BR-study-design-340-a-Hepatitis-B-Engerix-BR.png)
Hepatitis B vaccination (Engerix-B®) study design. 340 a Hepatitis B... | Download Scientific Diagram
![Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial - The Lancet Infectious Diseases Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d0abfc6a-4ce5-464d-800a-83fb54318e38/gr1.jpg)
Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial - The Lancet Infectious Diseases
![Hepatitis B Vaccination Booster Dose After 18 Years Maintains Long-Term Protection - Infectious Disease Advisor Hepatitis B Vaccination Booster Dose After 18 Years Maintains Long-Term Protection - Infectious Disease Advisor](https://www.infectiousdiseaseadvisor.com/wp-content/uploads/sites/16/2019/01/hbvvaccineg6481169481_1280727.jpg)
Hepatitis B Vaccination Booster Dose After 18 Years Maintains Long-Term Protection - Infectious Disease Advisor
![Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2458-14-991/MediaObjects/12889_2014_Article_7304_Fig3_HTML.jpg)
Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text
![Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine](https://www.annsaudimed.net/cms/asset/6f304f17-df9d-4079-b754-a62feaebeebe/0646-oa_ig.jpg)
Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine
![Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B - Journal of Hepatology Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2050894041/2059123767/gr1.jpg)
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B - Journal of Hepatology
![Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial - The Lancet Infectious Diseases Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ceea4ef1-7960-4941-880a-a46771b72458/gr1_lrg.jpg)
Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial - The Lancet Infectious Diseases
![Vaccines | Free Full-Text | Is There Any Opportunity to Provide an HBV Vaccine Booster Dose before Anti-Hbs Titer Vanishes? Vaccines | Free Full-Text | Is There Any Opportunity to Provide an HBV Vaccine Booster Dose before Anti-Hbs Titer Vanishes?](https://www.mdpi.com/vaccines/vaccines-08-00227/article_deploy/html/images/vaccines-08-00227-g001-550.jpg)